Wiser antimicrobial use gains further momentum

Antimicrobial resistance is spreading throughout the globe and is called the silent pandemic. To minimize unnecessary use of antibiotics, and thereby participate in the fight against antimicrobial resistance, AniCura is measuring its use of systemic antibiotics for the 6th year.

Since the launch of the QualiCura program in 2015, AniCura has been focusing on wiser use of antimicrobials. Through measurements, feedback and discussions of the results in the clinics, AniCura has seen a further decline in use from 7.7% in 2020 to 7.0% in this year.
The average use in each country that participated previously showed a decrease except for Sweden and Denmark, see figure below. The average for AniCura France was omitted due to too few clinics participating.

During one week in October, the clinics recorded what antimicrobial substances they used for systemic treatment or prophylaxis in dogs, together with indication of which diagnostic tools were used. This year, 14 countries with 190 clinics participated compared to 165 last year. Of the 33,544 dogs examined, 2,358 were treated with systemic antimi­crobials.

Implementation of AniCura’s antibiotic guidelines

To accelerate achievements and further ensure wiser antimicrobial use, AniCura’s strategic group for antibiotic use produced guidelines for the most common indications. These guidelines included recommendations for surgical antibiotic prophylaxis, wound infections and abscesses, gastro-intestinal disorders, skin infections, urinary tract infections, dental procedures, and lower and upper respiratory diseases. Together with a written document, the recommendations were presented in webinars to further enhance best quality of care.

The Study Result in Brief:

  • Surgical prophylaxis was the most common indication for dogs receiving antibiotics (23%) followed by wound infection including abscesses (20%), gastro-intestinal disorders (10%), skin infections (dermatitis, furunculosis etc) (9%), and urinary tract infections (8%).
  • The most used antimicrobial class was beta-lactam antibiotics (72%).
  • Most dogs were treated empirically (69%), i.e. without any diagnostic aid such as bacteriology and/or cytology results, which is lower than last year of 72%.
  • Duration of treatment varied from 1 to 125 days with a median of 7 days i.e. similar as last year’s result.